Obsidian Therapeutics, Inc.

OBX

Financials

10-QQuarter ended 06/30/2608/14/26

Disclosures

8-K/ACurrent report (amended)08/14/268-KCurrent report08/03/26

Prospectuses and Registrations

S-1Registration statement (IPO)08/28/26S-8Registration of securities for employees08/03/26424B3Prospectus07/02/26S-4/ARegistration (business combination, amended)07/02/26S-4/ARegistration (business combination, amended)06/30/26

Proxies

No matching filings.

Ownership

SC 13GBeneficial ownership10/05/26SC 13GBeneficial ownership08/11/26SC 13GBeneficial ownership08/10/26SC 13GBeneficial ownership08/10/26SC 13GBeneficial ownership08/10/26

Other

EFFECTRequest for effectiveness09/09/268-A12B8-A12B08/03/268-A12B/A8-A12B/A08/03/26CERTCEO/CFO certification08/03/26EFFECTRequest for effectiveness07/02/26